Click for best price
Porphyrias Drugs Market Size, Share 2022
Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system.
This report contains market size and forecasts of Porphyrias Drugs in global, including the following market information:
Global Porphyrias Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Porphyrias Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Porphyrias Drugs companies in 2021 (%)
The global Porphyrias Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Porphyrias Drugs include Lundbeck, Recordati Rare Diseases, Teva Pharmaceutical and Apotex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Porphyrias Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Porphyrias Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, by Type, 2021 (%)
Oral
Injectable
Global Porphyrias Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Porphyrias Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Porphyrias Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Porphyrias Drugs revenues share in global market, 2021 (%)
Key companies Porphyrias Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Porphyrias Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lundbeck
Recordati Rare Diseases
Teva Pharmaceutical
Apotex
| Report Attributes |
Report Details |
| Report Title |
Porphyrias Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Porphyrias Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Porphyrias Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Porphyrias Drugs Overall Market Size
2.1 Global Porphyrias Drugs Market Size: 2021 VS 2028
2.2 Global Porphyrias Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Porphyrias Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Porphyrias Drugs Players in Global Market
3.2 Top Global Porphyrias Drugs Companies Ranked by Revenue
3.3 Global Porphyrias Drugs Revenue by Companies
3.4 Global Porphyrias Drugs Sales by Companies
3.5 Global Porphyrias Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Porphyrias Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Porphyrias Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Porphyrias Drugs Players in Global Market
3.8.1 List of Global Tier 1 Porphyrias Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Porphyrias Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Porphyrias Drugs Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Injectable
4.2 By Type - Global Porphyrias Drugs Revenue & Forecasts
4.2.1 By Type - Global Porphyrias Drugs Revenue, 2017-2022
4.2.2 By Type - Global Porphyrias Drugs Revenue, 2023-2028
4.2.3 By Type - Global Porphyrias Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Porphyrias Drugs Sales & Forecasts
4.3.1 By Type - Global Porphyrias Drugs Sales, 2017-2022
4.3.2 By Type - Global Porphyrias Drugs Sales, 2023-2028
4.3.3 By Type - Global Porphyrias Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Porphyrias Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Porphyrias Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Porphyrias Drugs Revenue & Forecasts
5.2.1 By Application - Global Porphyrias Drugs Revenue, 2017-2022
5.2.2 By Application - Global Porphyrias Drugs Revenue, 2023-2028
5.2.3 By Application - Global Porphyrias Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Porphyrias Drugs Sales & Forecasts
5.3.1 By Application - Global Porphyrias Drugs Sales, 2017-2022
5.3.2 By Application - Global Porphyrias Drugs Sales, 2023-2028
5.3.3 By Application - Global Porphyrias Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Porphyrias Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Porphyrias Drugs Market Size, 2021 & 2028
6.2 By Region - Global Porphyrias Drugs Revenue & Forecasts
6.2.1 By Region - Global Porphyrias Drugs Revenue, 2017-2022
6.2.2 By Region - Global Porphyrias Drugs Revenue, 2023-2028
6.2.3 By Region - Global Porphyrias Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Porphyrias Drugs Sales & Forecasts
6.3.1 By Region - Global Porphyrias Drugs Sales, 2017-2022
6.3.2 By Region - Global Porphyrias Drugs Sales, 2023-2028
6.3.3 By Region - Global Porphyrias Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Porphyrias Drugs Revenue, 2017-2028
6.4.2 By Country - North America Porphyrias Drugs Sales, 2017-2028
6.4.3 US Porphyrias Drugs Market Size, 2017-2028
6.4.4 Canada Porphyrias Drugs Market Size, 2017-2028
6.4.5 Mexico Porphyrias Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Porphyrias Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Porphyrias Drugs Sales, 2017-2028
6.5.3 Germany Porphyrias Drugs Market Size, 2017-2028
6.5.4 France Porphyrias Drugs Market Size, 2017-2028
6.5.5 U.K. Porphyrias Drugs Market Size, 2017-2028
6.5.6 Italy Porphyrias Drugs Market Size, 2017-2028
6.5.7 Russia Porphyrias Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Porphyrias Drugs Market Size, 2017-2028
6.5.9 Benelux Porphyrias Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Porphyrias Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Porphyrias Drugs Sales, 2017-2028
6.6.3 China Porphyrias Drugs Market Size, 2017-2028
6.6.4 Japan Porphyrias Drugs Market Size, 2017-2028
6.6.5 South Korea Porphyrias Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Porphyrias Drugs Market Size, 2017-2028
6.6.7 India Porphyrias Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Porphyrias Drugs Revenue, 2017-2028
6.7.2 By Country - South America Porphyrias Drugs Sales, 2017-2028
6.7.3 Brazil Porphyrias Drugs Market Size, 2017-2028
6.7.4 Argentina Porphyrias Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Porphyrias Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Porphyrias Drugs Sales, 2017-2028
6.8.3 Turkey Porphyrias Drugs Market Size, 2017-2028
6.8.4 Israel Porphyrias Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Porphyrias Drugs Market Size, 2017-2028
6.8.6 UAE Porphyrias Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Lundbeck
7.1.1 Lundbeck Corporate Summary
7.1.2 Lundbeck Business Overview
7.1.3 Lundbeck Porphyrias Drugs Major Product Offerings
7.1.4 Lundbeck Porphyrias Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Lundbeck Key News
7.2 Recordati Rare Diseases
7.2.1 Recordati Rare Diseases Corporate Summary
7.2.2 Recordati Rare Diseases Business Overview
7.2.3 Recordati Rare Diseases Porphyrias Drugs Major Product Offerings
7.2.4 Recordati Rare Diseases Porphyrias Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Recordati Rare Diseases Key News
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Corporate Summary
7.3.2 Teva Pharmaceutical Business Overview
7.3.3 Teva Pharmaceutical Porphyrias Drugs Major Product Offerings
7.3.4 Teva Pharmaceutical Porphyrias Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Teva Pharmaceutical Key News
7.4 Apotex
7.4.1 Apotex Corporate Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Porphyrias Drugs Major Product Offerings
7.4.4 Apotex Porphyrias Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Apotex Key News
8 Global Porphyrias Drugs Production Capacity, Analysis
8.1 Global Porphyrias Drugs Production Capacity, 2017-2028
8.2 Porphyrias Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Porphyrias Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Porphyrias Drugs Supply Chain Analysis
10.1 Porphyrias Drugs Industry Value Chain
10.2 Porphyrias Drugs Upstream Market
10.3 Porphyrias Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Porphyrias Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Porphyrias Drugs in Global Market
Table 2. Top Porphyrias Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Porphyrias Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Porphyrias Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Porphyrias Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Porphyrias Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Porphyrias Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Porphyrias Drugs Product Type
Table 9. List of Global Tier 1 Porphyrias Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Porphyrias Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Porphyrias Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Porphyrias Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Porphyrias Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Porphyrias Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Porphyrias Drugs Sales (K Units), 2023-2028
Table 16. By Application ? Global Porphyrias Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Porphyrias Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Porphyrias Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Porphyrias Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Porphyrias Drugs Sales (K Units), 2023-2028
Table 21. By Region ? Global Porphyrias Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Porphyrias Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Porphyrias Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Porphyrias Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Porphyrias Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Porphyrias Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Porphyrias Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Porphyrias Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Porphyrias Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Porphyrias Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Porphyrias Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Porphyrias Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Porphyrias Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Porphyrias Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Porphyrias Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Porphyrias Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Porphyrias Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Porphyrias Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Porphyrias Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Porphyrias Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Porphyrias Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Porphyrias Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Porphyrias Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Porphyrias Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Porphyrias Drugs Sales, (K Units), 2023-2028
Table 46. Lundbeck Corporate Summary
Table 47. Lundbeck Porphyrias Drugs Product Offerings
Table 48. Lundbeck Porphyrias Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Recordati Rare Diseases Corporate Summary
Table 50. Recordati Rare Diseases Porphyrias Drugs Product Offerings
Table 51. Recordati Rare Diseases Porphyrias Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Teva Pharmaceutical Corporate Summary
Table 53. Teva Pharmaceutical Porphyrias Drugs Product Offerings
Table 54. Teva Pharmaceutical Porphyrias Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Apotex Corporate Summary
Table 56. Apotex Porphyrias Drugs Product Offerings
Table 57. Apotex Porphyrias Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Porphyrias Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global Porphyrias Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Porphyrias Drugs Production by Region, 2017-2022 (K Units)
Table 61. Global Porphyrias Drugs Production by Region, 2023-2028 (K Units)
Table 62. Porphyrias Drugs Market Opportunities & Trends in Global Market
Table 63. Porphyrias Drugs Market Drivers in Global Market
Table 64. Porphyrias Drugs Market Restraints in Global Market
Table 65. Porphyrias Drugs Raw Materials
Table 66. Porphyrias Drugs Raw Materials Suppliers in Global Market
Table 67. Typical Porphyrias Drugs Downstream
Table 68. Porphyrias Drugs Downstream Clients in Global Market
Table 69. Porphyrias Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Porphyrias Drugs Segment by Type
Figure 2. Porphyrias Drugs Segment by Application
Figure 3. Global Porphyrias Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Porphyrias Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Porphyrias Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Porphyrias Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Porphyrias Drugs Revenue in 2021
Figure 9. By Type - Global Porphyrias Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Porphyrias Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Porphyrias Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Porphyrias Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Porphyrias Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Porphyrias Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Porphyrias Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Porphyrias Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Porphyrias Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Porphyrias Drugs Sales Market Share, 2017-2028
Figure 19. US Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Porphyrias Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Porphyrias Drugs Sales Market Share, 2017-2028
Figure 24. Germany Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Porphyrias Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Porphyrias Drugs Sales Market Share, 2017-2028
Figure 33. China Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Porphyrias Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Porphyrias Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Porphyrias Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Porphyrias Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Porphyrias Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Porphyrias Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Porphyrias Drugs by Region, 2021 VS 2028
Figure 50. Porphyrias Drugs Industry Value Chain
Figure 51. Marketing Channels
